No significant differences were observed in age, BMI, ECOG performance status, chemotherapy regimen, hypertension, diabetes, hepatic cyst, ER, PR, Ki-67, HER-2, GGT, TBIL, Cr, MONO, NEUT, and PLT between the groups (Table 11). This evidence concerns the gene ERBB2 and Hypertension.